-

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Grifols, S.A. (GRFS) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Grifols, S.A. (“Grifols” or the “Company”) (NASDAQ: GRFS) investors concerning the Company’s possible violations of federal securities laws.

On January 8, 2024, after the market closed, Gotham City Research published a report alleging, among other things, that Grifols manipulated its debt and EBITDA figures to artificially lower its reported leverage.

On this news, Grifols’ stock price fell $2.43, or 21.8%, to close at $8.70 per share on January 9, 2024, thereby injuring investors.

If you purchased Grifols securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:GRFS

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Encourages Unicycive Therapeutics, Inc. (UNCY) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) common stock between December 29, 2025 and June 29, 2026, inclusive (the “Class Period”). Unicycive Therapeutics, Inc. investors have until November 2, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN UNICYCIVE THERAPEUTICS, INC. (UNCY)...

FuelCell Energy, Inc. (FCEL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of FuelCell Energy, Inc. (“FuelCell” or the “Company”) (NASDAQ: FCEL) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FUELCELL ENERGY, INC. (FCEL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by...

Law Offices of Howard G. Smith Encourages York Space Systems, Inc. (YSS) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased York Space Systems, Inc. (“York Space Systems” or the “Company”) (NYSE: YSS): (a) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the January 2026 initial public offering; and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”). York Space Syst...
Back to Newsroom